Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/12/2026 | Q4 | $12.2M | -- | -- | $0.03 | -- |
| 11/13/2025 | Q3 | $12.3M | $12.3M | $0.02 | $0.03 | -$0.01 |
| 09/18/2025 | Q2 | $12.4M | $12.4M | $0.07 | $0.06 | $0.02 |
| 05/08/2025 | Q1 | $13M | $12.7M | $0.01 | $0.03 | -$0.02 |
| 02/13/2025 | Q4 | $11.8M | $11.9M | -$0.07 | $0.02 | -$0.09 |
| 11/14/2024 | Q3 | $11.9M | $12M | $0.02 | $0.02 | $0.00 |
| 09/19/2024 | Q2 | $12M | $12.1M | -$0.10 | -$0.06 | -$0.04 |
| 05/09/2024 | Q1 | $11.9M | $12.1M | $0.00 | $0.02 | -$0.01 |
| 02/08/2024 | Q4 | $9.8M | $10.3M | -$0.00 | -- | -- |
| 11/09/2023 | Q3 | -- | -- | -$0.04 | -$0.03 | -$0.01 |
| 09/13/2023 | Q2 | -- | -- | $0.01 | $0.01 | -- |
| 05/11/2023 | Q1 | -- | -- | $0.01 | -- | -- |
| 02/09/2023 | Q4 | -- | -- | -$0.01 | $0.01 | -$0.02 |
| 11/10/2022 | Q3 | -- | -- | $0.01 | -- | -- |
| 09/22/2022 | Q2 | -- | -- | -$0.01 | -$0.01 | -- |
| 05/12/2022 | Q1 | -- | -- | -$0.01 | -$0.02 | $0.01 |
| 02/10/2022 | Q4 | -- | -- | -$0.02 | -- | -- |
| 11/11/2021 | Q3 | -- | -- | -$0.01 | -- | -- |
| 09/23/2021 | Q2 | -- | -- | -- | -- | -- |
| 05/13/2021 | Q1 | -- | -- | $0.00 | -- | -- |
| 02/11/2021 | Q4 | -- | -- | -$0.01 | -- | -- |
| 11/12/2020 | Q3 | -- | -- | $0.00 | -- | -- |
| 09/24/2020 | Q2 | -- | -- | -- | -- | -- |
| 05/14/2020 | Q1 | -- | -- | $0.00 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$0.03 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$0.00 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -- | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$0.00 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$0.03 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$0.01 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -- | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$0.01 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | -$0.03 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | -$0.04 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$0.02 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$0.03 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$0.04 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$0.02 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | -- | -- | -- |
| 03/31/2016 | Q1 | -- | -- | $0.00 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -$0.02 | -- | -- |
Research Solutions, Inc. reported $12.3M worth of top line sales in its most recent quarter.
Research Solutions, Inc. announced earnings per share of $0.02 which represents a miss of analyst forecast a $0.03 per share.
Research Solutions, Inc. reported $5.9M that represents $0.18 per share over the last quarter.
Research Solutions, Inc.'s earnings are forecast to grow from $0.04 per share to $0.11 per share next year representing an increase of 248.26%.
Research Solutions, Inc.'s next earnings date is February 12, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.